Novartis bets big on India, builds its largest global R&D hub outside Switzerland

Novartis is significantly expanding its biomedical research and drug development operations in India, positioning it as a key global hub outside Switzerland. With over 9,000 employees, Indian teams now contribute to nearly every Novartis molecule in late-stage development, driving high-value, science- and data-led innovation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/lYqgXyR
via IFTTT